scholarly article | Q13442814 |
P819 | ADS bibcode | 2012PLoSO...733848S |
P356 | DOI | 10.1371/JOURNAL.PONE.0033848 |
P8608 | Fatcat ID | release_tgubv26zkbdptnenv2gw7obhxe |
P932 | PMC publication ID | 3307769 |
P698 | PubMed publication ID | 22442729 |
P5875 | ResearchGate publication ID | 221971491 |
P50 | author | Kurt J. Sales | Q40906797 |
P2093 | author name string | Henry N Jabbour | |
Arieh A Katz | |||
Jason R Sutherland | |||
P2860 | cites work | Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors | Q24648434 |
Inflammation and cancer | Q24649640 | ||
Cyclooxygenases: structural, cellular, and molecular biology | Q29616510 | ||
A comprehensive characterization of the peptide and protein constituents of human seminal fluid | Q33205745 | ||
Interleukin-11 in endometrial adenocarcinoma is regulated by prostaglandin F2alpha-F-prostanoid receptor interaction via the calcium-calcineurin-nuclear factor of activated T cells pathway and negatively regulated by the regulator of calcineurin-1. | Q33556402 | ||
Prostaglandin F(2alpha)-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway | Q33590672 | ||
Seminal fluid drives expansion of the CD4+CD25+ T regulatory cell pool and induces tolerance to paternal alloantigens in mice | Q33770707 | ||
Hypoxia and prostaglandin E receptor 4 signalling pathways synergise to promote endometrial adenocarcinoma cell proliferation and tumour growth | Q33903900 | ||
Worldwide burden of cervical cancer in 2008. | Q34176394 | ||
Seminal plasma promotes the expression of tumorigenic and angiogenic genes in cervical adenocarcinoma cells via the E-series prostanoid 4 receptor. | Q34507123 | ||
The intravaginal absorption of male generated hormones and their possible effect on female behaviour | Q34661505 | ||
Infection and cervical neoplasia: facts and fiction. | Q34843163 | ||
Cyclooxygenase enzymes and prostaglandins in reproductive tract physiology and pathology. | Q35547033 | ||
Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium. | Q35581225 | ||
Prostaglandin receptor signalling and function in human endometrial pathology. | Q35893894 | ||
The transport of chemicals in semen | Q36100233 | ||
Seminal plasma and male factor signalling in the female reproductive tract. | Q36134888 | ||
Morphology and functions of the human seminal vesicle | Q36372678 | ||
HPV infection and number of lifetime sexual partners are strong predictors for 'natural' regression of CIN 2 and 3. | Q36648468 | ||
Male reproductive proteins and reproductive outcomes | Q36771788 | ||
Inflammation: its role and interplay in the development of cancer, with special focus on gynecological malignancies | Q36974953 | ||
Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1 | Q37222340 | ||
Seminal plasma activates cyclooxygenase-2 and prostaglandin E2 receptor expression and signalling in cervical adenocarcinoma cells | Q37222349 | ||
Seminal plasma and prostaglandin E2 up-regulate fibroblast growth factor 2 expression in endometrial adenocarcinoma cells via E-series prostanoid-2 receptor-mediated transactivation of the epidermal growth factor receptor and extracellular signal-re | Q37223974 | ||
Prostaglandin F2alpha-F-prostanoid receptor signaling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinoma | Q37266333 | ||
Cervical cancer: the sub-Saharan African perspective | Q37332707 | ||
COX-2, VEGF and tumour angiogenesis. | Q37542134 | ||
Inflammatory pathways in female reproductive health and disease. | Q37606140 | ||
Activating T regulatory cells for tolerance in early pregnancy - the contribution of seminal fluid | Q37624139 | ||
The role of inflammation in HPV carcinogenesis. | Q37785656 | ||
Cyclooxygenase-2 in oncogenesis | Q37824155 | ||
Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells | Q38360120 | ||
Activation of telomerase by seminal plasma in malignant and normal cervical epithelial cells | Q39540555 | ||
Seminal plasma differentially regulates inflammatory cytokine gene expression in human cervical and vaginal epithelial cells | Q40136370 | ||
Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange | Q40144444 | ||
Involvement of cyclooxygenase-2--prostaglandin E2 pathway in interleukin-8 production in gastric cancer cells | Q40213489 | ||
Strategies for global control of cervical cancer | Q40564877 | ||
Effect of human seminal fluid on production of messenger ribonucleic acid for metalloproteinase 2 and metalloproteinase 9 in cervical epithelial carcinoma cells | Q40929082 | ||
Seminal plasma components stimulate interleukin-8 and interleukin-10 release. | Q40953569 | ||
The epidemiology of cervical carcinogenesis | Q40989058 | ||
Induction of messenger RNA for the 70 kDa heat shock protein in HeLa cells and the human endocervix following exposure to semen: implications for antisperm antibody production and susceptibility to sexually transmitted infections | Q41080308 | ||
Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinomas in vitro | Q41544432 | ||
Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures | Q41716249 | ||
Role of high molecular weight seminal vesicle proteins in eliciting the uterine inflammatory response to semen in mice | Q47328310 | ||
Seminal fluid induces leukocyte recruitment and cytokine and chemokine mRNA expression in the human cervix after coitus. | Q50971519 | ||
Cross-presentation of male seminal fluid antigens elicits T cell activation to initiate the female immune response to pregnancy. | Q51634186 | ||
Combating angiogenesis early: potential of targeting tumor-recruited neutrophils in cancer therapy. | Q51652943 | ||
Interleukin-6 (IL-6) production in carcinoma of the cervix. | Q53458293 | ||
Cervical cancer screening: who is not screened and why? | Q53858349 | ||
Human papillomavirus HPV-16, 18, 52 and 58 integration in cervical cells of HIV-1-infected women. | Q54430551 | ||
Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer | Q58212506 | ||
Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis | Q62488559 | ||
Uterine epithelial cells synthesize granulocyte-macrophage colony-stimulating factor and interleukin-6 in pregnant and nonpregnant mice | Q67550416 | ||
Tumor-associated angiogenesis in prostate cancer | Q71614828 | ||
Tumor angiogenesis in human lung adenocarcinoma | Q71649284 | ||
Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia | Q71751782 | ||
High cyclooxygenase-2 expression in stage IB cervical cancer with lymph node metastasis or parametrial invasion | Q73469326 | ||
Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells | Q73509785 | ||
Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers | Q73821703 | ||
Vascular endothelial growth factor in cervical carcinoma | Q74061059 | ||
CD31 expression in benign, borderline, and malignant epithelial ovarian tumors: an immunohistochemical and serological analysis | Q77450411 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cervical adenocarcinoma | Q18556035 |
P304 | page(s) | e33848 | |
P577 | publication date | 2012-03-19 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Seminal plasma enhances cervical adenocarcinoma cell proliferation and tumour growth in vivo | |
P478 | volume | 7 |
Q42202724 | CCR5 expression is elevated in cervical cancer cells and is up-regulated by seminal plasma. |
Q57476687 | Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature |
Q60046850 | Inflammatory Cytokine Profiles of Semen Influence Cytokine Responses of Cervicovaginal Epithelial Cells |
Q26742070 | Seminal Fluid-Mediated Inflammation in Physiology and Pathology of the Female Reproductive Tract |
Q38088289 | Seminal fluid and the generation of regulatory T cells for embryo implantation. |
Q33598471 | Seminal plasma induces global transcriptomic changes associated with cell migration, proliferation and viability in endometrial epithelial cells and stromal fibroblasts |
Q34199061 | Seminal plasma induces the expression of IL-1α in normal and neoplastic cervical cells via EP2/EGFR/PI3K/AKT pathway |
Q27024447 | The regulation of inflammatory pathways and infectious disease of the cervix by seminal fluid |